Intrathecal administration of naringenin improves motor dysfunction and neuropathic pain following compression spinal cord injury in rats: relevance to its antioxidant and anti-inflammatory activities

키워드

참고문헌 (50)

1. Thuret S, "Therapeutic interventions after spinal cord injury", Nat Rev Neurosci, 7, pp.628~643 (2006)
2. Fakhri S, "Effects of astaxanthin on sensory-motor function in a compression model of spinal cord injury : Involvement of ERK and AKT signalling pathway", Eur J Pain, 23, pp.750~764 (2019)
3. Fakhri S, "Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury", Brain Res Bull, 143, pp.217~224 (2018)
4. Naseem M, "Role of melatonin in traumatic brain injury and spinal cord injury", ScientificWorldJournal, 2014, pp.586270~ (2014)
5. Esposito E, "Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury", J Pineal Res, 45, pp.149~156 (2008)
6. Jia Z, "Oxidative stress in spinal cord injury and antioxidant-based intervention", Spinal Cord, 50, pp.264~274 (2012)
7. Faden AI, "Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury", Br J Pharmacol, 173, pp.681~691 (2016)
8. Franz S, "Neurological aspects of spinal cord injury", pp.283~302 (2017), Springer
9. Backonja MM, "Rational multidrug therapy in the treatment of neuropathic pain", Curr Pain Headache Rep, 10, pp.34~38 (2006)
10. Hare JT, "Grapefruit juice and potential drug interactions", Consult Pharm, 18, pp.466~472 (2003)
11. Palma-Duran SA, "Serum levels of phytoestrogens as biomarkers of intake in Mexican women", Int J Food Sci Nutr, 66, pp.819~825 (2015)
12. Pinho-Ribeiro FA, "Naringenin reduces inflammatory pain in mice", Neuropharmacology, 105, pp.508~519 (2016)
13. Hu CY, "Analgesic effects of naringenin in rats with spinal nerve ligation-induced neuropathic pain", Biomed Rep, 2, pp.569~573 (2014)
14. Al-Rejaie SS, "Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy", Neurol Res, 37, pp.924~933 (2015)
15. Kaulaskar S, "Effects of naringenin on allodynia and hyperalgesia in rats with chronic constriction injury-induced neuropathic pain", Zhong Xi Yi Jie He Xue Bao, 10, pp.1482~1489 (2012)
16. Pinho-Ribeiro FA, "The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation", J Nutr Biochem, 33, pp.8~14 (2016)
17. Manchope MF, "Naringenin inhibits superoxide anion-induced inflammatory pain : role of oxidative stress, cytokines, Nrf-2 and the NO-cGMP-PKG-KATP channel signaling pathway", PLoS One, 11, pp.e0153015~ (2016)
18. Fakhri S, "Intrathecal administration of melatonin ameliorates the neuroinflammation-mediated sensory and motor dysfunction in a rat model of compression spinal cord injury", Curr Mol Pharmacol, 14, pp.646~657 (2021)
19. Mestre C, "A method to perform direct transcutaneous intrathecal injection in rats", J Pharmacol Toxicol Methods, 32, pp.197~200 (1994)
20. Kauppila T, "Cold exposure enhances tactile allodynia transiently in mononeuropathic rats", Exp Neurol, 161, pp.740~744 (2000)
21. Hama AT, "Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain", Pharmacol Biochem Behav, 97, pp.249~255 (2010)
22. Janicki P, "Detection of antagonist activity for narcotic analgesics in mouse hot-plate test", Pharmacol Biochem Behav, 10, pp.623~626 (1979)
23. Basso DM, "A sensitive and reliable locomotor rating scale for open field testing in rats", J Neurotrauma, 12, pp.1~21 (1995)
24. Samini F, "Curcumin pretreatment attenuates brain lesion size and improves neurological function following traumatic brain injury in the rat", Pharmacol Biochem Behav, 110, pp.238~244 (2013)
25. Rahman I, "Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method", Nat Protoc, 1, pp.3159~3165 (2006)
26. Aebi H, "Methods of enzymatic analysis", pp.673~684 (1974), Academic Press
27. Masoudi A, "Neuroprotective effects of astaxanthin in a rat model of spinal cord injury", Behav Brain Res, 329, pp.104~110 (2017)
28. Nouri Z, "On the neuroprotective effects of naringenin : pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective", Biomolecules, 9, pp.690~ (2019)
29. Mao L, "Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-α, and matrix metalloproteinase-9 after spinal cord injury in mice", Mediators Inflamm, 2010, pp.238321~ (2010)
30. Alghamdi BS, "The neuroprotective role of melatonin in neurological disorders", J Neurosci Res, 96, pp.1136~1149 (2018)
31. Stetler-Stevenson WG, "Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix", Am J Pathol, 148, pp.1345~1350 (1996)
32. Shibata N, "Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer’s disease", Neurobiol Aging, 26, pp.1011~1014 (2005)
33. Lorenzl S, "Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson’s disease", Exp Neurol, 178, pp.13~20 (2002)
34. Beuche W, "Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis", Neuroreport, 11, pp.3419~3422 (2000)
35. Noble LJ, "Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events", J Neurosci, 22, pp.7526~7535 (2002)
36. Yang R, "Epidemiology of spinal cord injuries and risk factors for complete injuries in Guangdong, China : a retrospective study", PLoS One, 9, pp.e84733~ (2014)
37. Wells JE, "An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice", J Neurosci, 23, pp.10107~10115 (2003)
38. Zhang H, "Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury", Neurotherapeutics, 8, pp.206~220 (2011)
39. Piao MS, "Melatonin improves functional outcome via inhibition of matrix metalloproteinases-9 after photothrombotic spinal cord injury in rats", Acta Neurochir (Wien), 156, pp.2173~2182 (2014)
40. Jae-Won Jang, "Activation of Matrix Metalloproteinases-9 after Photothrombotic Spinal Cord Injury Model in Rats", 대한신경외과학회지, 50(4), pp.288~292 (2011), 대한신경외과학회
41. Bai X, "Protective effect of naringenin in experimental ischemic stroke : down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression", Neurochem Res, 39, pp.1405~1415 (2014)
42. Hsu JY, "Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury", J Neurosci, 26, pp.9841~9850 (2006)
43. Shi LB, "Naringenin inhibits spinal cord injury-induced activation of neutrophils through miR-223", Gene, 592, pp.128~133 (2016)
44. Puspitasari V, "Glial fibrillary acidic protein serum level as a predictor of clinical outcome in ischemic stroke", Open Access Maced J Med Sci, 7, pp.1471~1474 (2019)
45. Khajevand-Khazaei MR, "Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat", Eur J Pharmacol, 826, pp.114~122 (2018)
46. Krishna Chandran AM, "Neuroprotective role of naringenin against methylmercury induced cognitive impairment and mitochondrial damage in a mouse model", Environ Toxicol Pharmacol, 71, pp.103224~ (2019)
47. Chtourou Y, "Protective effects of naringenin on iron-overload-induced cerebral cortex neurotoxicity correlated with oxidative stress", Biol Trace Elem Res, 158, pp.376~383 (2014)
48. Muthaiah VP, "Neuroprotective role of naringenin on carbaryl induced neurotoxicity in mouse neuroblastoma cells", J Pharmacol Pharmacother, 4, pp.192~197 (2013)
49. Xu XH, "Protective effect of naringenin on glutamate-induced neurotoxicity in cultured hippocampal cells", Arch Biol Sci, 67, pp.639~646 (2015)
50. Giangregorio L, "Bone loss and muscle atrophy in spinal cord injury : epidemiology, fracture prediction, and rehabilitation strategies", J Spinal Cord Med, 29, pp.489~500 (2006)

관련 논문AI추천